Patients with severe psoriasis are also at a significant increase for developing advanced liver fibrosis, new research shows
Psoriasis patients have a lower risk of serious infection with specific biologic and non-biologic medications than with methotrexate, based on new research results.
Biological therapies prescribed for rheumatic diseases may also reduce their long-term risks of cardiovascular diseases (CVD), new research shows.
A new study in JAMA Dermatology raises an interesting question for physicians who treat psoriasis patients. Does methotrexate work best in patients with plaque psoriasis alone or patients who have both psoriasis and arthritis?
Psoriasis could increase the risk of sexual dysfunction, particularly in patients with psychological comorbidity, shows a study published in JAMA Dermatology.
Online care and in-person care are equally effective at improving psoriasis symptoms, shows a study published in JAMA Network Open.
(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.
Increased mortality described in the first study to review all-cause mortality and cause-specific mortality in patients with psoriasis.
Doctors should be vigilant about recognizing the signs and symptoms of patients who may develop ILD in order to prevent catastrophic complications, such as respiratory failure.
Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.